FDA Now Regulates E-Cigarettes and Vaporizers


FDA Now Regulates E-Cigarettes and Vaporizers
May 24, 2018 Categories: FDA updates

Pin It

FDA Now Regulates E-Cigarettes and Vaporizers

FDA’s Deeming Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products.

Mitch Zeller, Director of FDA’s Center for Tobacco Products posted in his blog that

  • It will become illegal nationwide to sell cigars, hookah tobacco, and e-cigarettes to anyone under age 18 and retailers will need to check photo ID of anyone under age 27.
  • Retailers will not be allowed to give away free samples of newly deemed tobacco products.
  • Retailers will not be allowed to sell cigars, hookah tobacco, and e-cigarettes in a vending machine where anyone under age 18 has access at any time.

Nicopure Labs, LLC, a leading American manufacturer of e-liquids, announced May 8, 2018, they have filed a lawsuit in the federal district court in Washington, D.C., challenging the new “deeming” rule.

Jason Del Giudice, the company’s chief technology officer and co-founder, stated:

“FDA’s rule does not protect the consumer from low quality products; instead, it places a disproportionate and unjustified regulatory burden on compliant companies such as ourselves, who are determined to drive the industry to the highest standards of quality and innovation.”

Your Comment

Recent Updates

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

July 25, 2018

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

July 18, 2018

Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...

July 17, 2018